Huang, W., Chen, Y., Wu, C., & Ko, Y. (2021). Cardiovascular outcomes and healthcare costs of liraglutide versus basal insulin for type 2 diabetes patients at high cardiovascular risk. Nature Portfolio.
Style de citation Chicago (17e éd.)Huang, Wan-Chun, Yen-Chou Chen, Chung-Hsuen Wu, et Yu Ko. Cardiovascular Outcomes and Healthcare Costs of Liraglutide Versus Basal Insulin for Type 2 Diabetes Patients at High Cardiovascular Risk. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Huang, Wan-Chun, et al. Cardiovascular Outcomes and Healthcare Costs of Liraglutide Versus Basal Insulin for Type 2 Diabetes Patients at High Cardiovascular Risk. Nature Portfolio, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.